Exagen Operating Expenses Growth & History (XGN)
Exagen's operating expenses was $52.9M for fiscal 2025.
View full Exagen company overviewExagen annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $52.9M | $6.1M | +13.09% |
| 2024 | 2024-12-31 | $46.7M | −$28.6M | −37.99% |
| 2023 | 2023-12-31 | $75.4M | −$16.2M | −17.71% |
| 2022 | 2022-12-31 | $91.6M | $19.2M | +26.60% |
| 2021 | 2021-12-31 | $72.4M | $15.2M | +26.60% |
| 2020 | 2020-12-31 | $57.2M | $7.5M | +15.04% |
| 2019 | 2019-12-31 | $49.7M | $12.4M | +33.14% |
| 2018 | 2018-12-31 | $37.3M | — | — |
Exagen quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $13.9M | $914,000 | +7.02% |
| Q1 2026 | 2026-03-31 | $13.6M | $1.1M | +9.06% |
| Q4 2025 | 2025-12-31 | $14.2M | $2.3M | +19.57% |
| Q3 2025 | 2025-09-30 | $13.2M | −$4.0M | −23.27% |
| Q2 2025 | 2025-06-30 | $13.0M | −$4.6M | −26.21% |
| Q1 2025 | 2025-03-31 | $12.5M | −$4.9M | −28.30% |
| Q4 2024 | 2024-12-31 | $11.9M | −$7.1M | −37.29% |
| Q3 2024 | 2024-09-30 | $17.2M | −$1.3M | −7.11% |
| Q2 2024 | 2024-06-30 | $17.7M | −$1.4M | −7.35% |
| Q1 2024 | 2024-03-31 | $17.4M | −$1.5M | −8.02% |
| Q4 2023 | 2023-12-31 | $18.9M | −$8.4M | −30.80% |
| Q3 2023 | 2023-09-30 | $18.5M | −$4.1M | −18.00% |
| Q2 2023 | 2023-06-30 | $19.1M | −$2.6M | −12.08% |
| Q1 2023 | 2023-03-31 | $18.9M | −$1.1M | −5.66% |
| Q4 2022 | 2022-12-31 | $27.3M | $8.4M | +44.26% |
| Q3 2022 | 2022-09-30 | $22.5M | $3.8M | +20.20% |
| Q2 2022 | 2022-06-30 | $21.7M | $3.2M | +17.05% |
| Q1 2022 | 2022-03-31 | $20.1M | $3.9M | +24.26% |
| Q4 2021 | 2021-12-31 | $18.9M | $3.5M | +22.78% |
| Q3 2021 | 2021-09-30 | $18.8M | $4.2M | +28.80% |
| Q2 2021 | 2021-06-30 | $18.5M | $6.1M | +49.73% |
| Q1 2021 | 2021-03-31 | $16.2M | $1.3M | +9.11% |
| Q4 2020 | 2020-12-31 | $15.4M | $2.4M | +18.03% |
| Q3 2020 | 2020-09-30 | $14.6M | $2.0M | +15.60% |
| Q2 2020 | 2020-06-30 | $12.4M | −$519,000 | −4.03% |
| Q1 2020 | 2020-03-31 | $14.8M | $3.7M | +32.97% |
| Q4 2019 | 2019-12-31 | $13.1M | — | — |
| Q3 2019 | 2019-09-30 | $12.6M | $3.2M | +34.63% |
| Q2 2019 | 2019-06-30 | $12.9M | — | — |
| Q1 2019 | 2019-03-31 | $11.1M | — | — |
| Q3 2018 | 2018-09-30 | $9.4M | — | — |
Exagen operating expenses trends
Over the last five fiscal years, Exagen's operating expenses decreased from $57.2M to $52.9M, a change of −$4.3M. The latest reported quarter, Q2 2026, shows $13.9M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Exagen source filings ↗